Final results from the DREAMM-2 trial suggest that belantamab mafodotin produces durable responses in patients with relapsed/refractory multiple myeloma.
Aphexda (motixafortide) is expected to be available later this month.
Patients from racial and ethnic minority groups are still underrepresented in cancer research, despite efforts to make clinical trials more diverse.
Melflufen plus daratumumab and dexamethasone produced better outcomes than daratumumab alone in a phase 3 trial of patients with relapsed/refractory multiple myeloma.
The combination of oral mezigdomide and dexamethasone has shown activity in patients with relapsed/refractory multiple myeloma.
About 1 in 5 immunosuppressed individuals have no detectable IgG anti-spike antibodies after 3 or more COVID-19 vaccinations, a new study suggests.
Some cancer centers have lifted mask mandates that were intended to protect patients from COVID-19, despite patient concerns.
Cancer survivors with functional disabilities have higher health care usage and medical costs than survivors without disabilities, data suggest.
Black patients are underrepresented in studies of multiple myeloma used to support IMWG guidelines, researchers found.
America’s pharmaceutical giants are suing this summer to block the federal government’s first effort at drug price regulation.
Deaths in patients with COVID-19 and cancer made up 81% of excess deaths among cancer patients during the first 2 years of the pandemic.
Researchers found a higher risk of VTE in patients with cancer and COVID-19 who were receiving systemic cancer therapies.
The Preserving Patient Access to Home Infusion Act could make home infusions more accessible, particularly for patients with cancer.
Cancer death rates have declined in the United States in recent years, but the declines are greater in urban than in rural areas, data suggest.
Industry-sponsored cancer trials are more likely to have consent documents translated to languages other than English, a study suggests.
Elrexfio is expected to be available in the coming weeks.
In an analysis of more than 10,000 cancer clinical trials, less than half had results reported within 1 year of trial completion.
New research suggests that, in the United States, cancer was underdiagnosed during the first year of the COVID-19 pandemic.
Excessive alcohol consumption may be common among cancer survivors and cancer patients currently receiving treatment, a new study suggests.
Oncology professionals share what #MedTwitter means to them and where they might go if Twitter (now X) becomes obsolete.